James King

Since joining Kirkland, James has been involved in the following matters:

• PAI Partners on the strategic minority investment in its business by Dyal Capital
• Basalt Infrastructure Partners on the strategic investment made by Colliers into Basalt 
• 17Capital on the strategic partnership with Oaktree under which it will sell a majority stake to Oaktree
• Montana Capital Partners on its sale to PGIM, the global asset management business of Prudential Financial, Inc.  
• CapVest in connection with the single-asset GP-led secondary transaction involving Curium Pharma
• Helios Holdings Limited on its combination with Fairfax Africa Holdings Corporation
• Nordic Capital on the strategic minority investment by Ottawa Avenue Private Capital in the firm 

Prior to joining Kirkland, James worked on the following matters:

• Advising a large UK manager on the structuring of a €500 million investment by a European pension fund into a managed account with a private equity fund-of-funds strategy
• Advising a UK multi-asset manager on the £107 million investment by a Korean investor in a portfolio of renewable energy assets
• Advising a UK multi-asset manager on the structuring of a new £500 million renewable energy fund
• Advising a Nigerian fund manager on the formation of its third private equity fund
• Advising a UK debt fund manager on the establishment of its fourth real estate debt fund
• Advising a large European private equity manager on its carried interest and incentivisation arrangements
• Advising a UK multi-asset fund manager on the implementation of ESG policies and procedures
• Advising the management team of a pharmaceutical company on the proposed spin out and associated third party fund raising in relation to certain portfolio companies in the pharmaceuticals industry
• Advising X2 Resources, a mid-tier diversified mining and metals group, with a large scale fund raising
• Advising Grainger plc on the restructuring of its UK and Jersey based property joint venture with APG
• Acting for Pershing Square Holdings on its introduction to the London Stock Exchange
• Acting for BACIT on its combination with the Syncona life sciences fund and investment by the Wellcome Trust and Cancer Research UK
• Acting for LafargeHolcim Ltd on the divestment of several worldwide assets to CRH plc for EUR 6.5 billion as part of its antitrust commitments ahead of the merger between Holcim Ltd and Lafarge S.A (which created LafargeHolcim Ltd)
• Advising Jefferies and Credit Suisse as sponsor and joint bookrunners on the EUR 250 million IPO of Apax Global Alpha Limited

Clifford Chance LLP, London

• Associate (2017–2019)

Freshfields Bruckhaus Deringer LLP, London

• Associate (2014–2017)
• Trainee Solicitor (2012–2014)